Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety

NCT01551303 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01551303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01551303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2009
Completion date
December 31, 2012
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

social intelligence